Hematologic side effects of biologics and kinase inhibitors used in rheumatologic diseases: a review of the current evidence

Treatment options for various rheumatologic diseases have been limited until the introduction of biologic agents and kinase inhibitor therapy in recent decades. Since their arrival, they have steadily been integrated into routine management. Given their wide use and overall successful outcomes, it b...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhandari, Sambhawana, Baral, Maun Ranjan, Barbery, Matthew, Rudinskaya, Alla, Sostin, Oleg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243812/
https://www.ncbi.nlm.nih.gov/pubmed/35759025
http://dx.doi.org/10.1007/s00277-022-04896-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243812/
https://www.ncbi.nlm.nih.gov/pubmed/35759025
http://dx.doi.org/10.1007/s00277-022-04896-7

Ejemplares similares